Skip to main content
. 2024 May 10;37:12751. doi: 10.3389/ti.2024.12751

TABLE 2.

Patient outcomes.

Postoperative and survival outcomes with and without clinically significant airway ischemia
CSAI (N = 82) Non-CSAI (N = 135) p-values
Postoperative Outcomes
PGD grade 3 at 48–72 h 24 (29.3%) 40 (29.6%) 0.95
Post-Op ECMO 11 (13.4%) 15 (11.1%) 0.61
Ventilator Support >5 days 24 (29.3%) 37 (27.4%) 0.77
Atrial Fibrillation 36 (43.9%) 60 (44.4%) 0.94
Major Bleeding 11 (13.4%) 10 (7.4%) 0.15
Acute Cellular Rejection 9 (11%) 8 (5.9%) 0.19
Hospital Length of Stay 32.68 (30.13) 25.90 (29.64) 0.12
ICU Length of Stay 20.77 (26.38) 15.43 (21.48) 0.11
Hospital Readmission within 1 year 66 (52.4%) 103 (39.6%) 0.09
Tracheostomy 21 (25.6%) 30 (22.2%) 0.57
Dialysis 12 (14.6%) 13 (9.6%) 0.27
Pneumonia 20 (24.4%) 23 (17.0%) 0.19
Survival
 90-day 78 (95.1%) 131 (97%) 0.47
 1 year 66 (80.5%) 124 (91.9%) 0.05
 3 years 55 (67.1%) 105 (77.8%) 0.08

Continuous variables expressed as Mean (SD); Categorical variables expressed as frequency (%).

CSAI: clinically significant airway ischemia, PGD: primary graft dysfunction.